TUESDAY, Dec. 14, 2021 (HealthDay News) — Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people at high risk for severe illness. The latest results, which reinforce an earlier analysis released in November, show that Pfizer’s drug cutContinue Reading

TUESDAY, Dec. 14, 2021 (HealthDay News) — Pandemic lockdowns may have led fewer Americans to seek pain treatment last year, but folks who did seek help had higher-than-usual odds of receiving dangerous opioid painkillers, a new study says. And that could lead to a worsening of the opioid epidemic, researchersContinue Reading

TUESDAY, Dec. 14, 2021 (HealthDay News) — A statewide indoor mask mandate will be reintroduced in California on Wednesday and last one month, officials in America’s largest state said Monday. “To ensure that we collectively protect the health and well-being of all Californians; keep schools open for in-person instruction; andContinue Reading

TUESDAY, Dec. 14, 2021 (HealthDay News) — For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtypeContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the Omicron variant falls significantly short, but a booster shot provides considerable protection, according to the first real-world study of how effective vaccines are against the rapidly spreading new form ofContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — Older adults have a higher risk of delirium after hip and knee surgery if they’re taking anxiety, depression or insomnia drugs, researchers say. “Our findings show that different classes of medicine are riskier than others when it comes to causing delirium after surgery,Continue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based onContinue Reading